Alexion up 5% on difficulty in certain PNH patients switching from Soliris to Ra Pharma's RA101495 [Seeking Alpha]
RA PHARMACEUTICALS (RARX)
Last ra pharmaceuticals earnings: 11/7 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
rapharma.com/news-investors
Company Research
Source: Seeking Alpha
Alexion up 5% on difficulty in certain PNH patients switching from Soliris to Ra Pharma's RA101495APhase 2 clinical trial assessing Ra Pharmaceuticals' (RARX+2.4%) subcutaneously administered RA101495 in patients with paroxysmal nocturnal hemoglobinuria (PNH) showed a positive effect in patients who were naive to Alexion Therapeutics' (ALXN+5.3%) Soliris (eculizumab). The data weren't so good for patients on Soliris therapy, however.In 10 PNH patients naive to Soliris, treatment with RA101495 met the primary endpoint of a sustained reduction in lactate dehydrogenase (LDH) levels from baseline to the mean of weeks 6 - 12 (p=0.002) with near-complete suppression of complement activity. Half (n=3/6) of the transfusion-dependent subjects prior to enrollment remained transfusion-free during the study period.In patients on Soliris who switched to RA101495, five transfusion-independent patients maintained stable LDH levels with one withdrawal due to breakthrough hemolysis (return of PNH symp
Show less
Read more
Impact Snapshot
Event Time:
RARX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RARX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RARX alerts
High impacting RA PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics